Autotransfusion Systems Market Growth, Size | Forecast 2031
Autotransfusion Systems Market Growth, Size | Forecast 2031
Segments - Autotransfusion Systems Market by Product Type (Autotransfusion Systems and Consumables & Accessories), Application (Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological, Cardiovascular Surgeries, Organ & Tissue Transplantation, Trauma Procedures, and Others), End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-5465
| 4.7 Rating
| 85 Reviews
| 198 Pages
| Format :
Report Description
The global autotransfusion systems market size was USD 268.9 Mn in 2022 and is likely to reach USD 413.53 Mn by 2031, expanding at a CAGR of 5.3% during 2023 – 2031. Increasing demand for reliable blood management systems to reduce complications and improve patient safety during surgeries boost the market.
Autotransfusion systems are embedded with sophisticated devices that provide autologous blood during surgeries. It collects and reinfuses the blood of a patient. The system is widely utilized in cardiac surgeries, orthopedic surgeries, and major trauma cases. These devices prevents the clotting of the collected blood and reduces the risk of blood contamination.
The COVID-19 pandemic had a negative impact on the autotransfusion systems market. During the pandemic, healthcare resources had been redirected to combat COVID-19, which decreased the number of surgical procedures to a certain limit. This led to a sharp decline in the demand for devices with autotransfusion systems and significantly hampered the market. According to Stanford Medicine, the nonurgent surgery rates dropped by 48% during the seven weeks of mid-march, as the Centers for Medicare and Medicaid Services recommended hospitals to minimize and postpone elective surgeries.
Autotransfusion Systems Market Dynamics
Major Drivers
Rising number of surgical procedures is expected to drive the autotransfusion system market during the forecast period. Autotransfusion systems offer a safer alternative to donor blood transfusions. The utilization of a patient blood reduces the risk of complications such as infections, immune reactions, and mismatched blood transfusions. Surgical procedures become increasingly common; therefore, the need for safe blood management techniques becomes increasingly important, which makes autotransfusion systems an essential tool in enhancing patient safety.
- According to the report published by the National Library of Medicine in July 2020, over 310 million surgeries are performed each year across the globe, in which around 40 to 50 million are performed in the US and 20 million in Europe.
Existing Restraints
Growing use of hemostatic devices and the demand for minimally invasive surgeries is expected to hinder the market in the coming years. The increasing preference for minimally invasive surgical procedures minimizes hospitalization. This surgery has a low risk of blood loss compared to traditional open surgeries, which further decline the demand for autotransfusion systems. These all factors affect the demand for blood management systems, including autotransfusion.
Emerging Opportunities
Ongoing research activities and technological advancement in blood conservation are likely to create lucrative opportunities for the key players competing in the market in the coming years. Innovations, such as improved blood processing technologies and advanced filtration methods, are further enhancing autotransfusion systems capabilities. Thus, manufacturers are developing advanced technologies to improve the reliability and accuracy of autotransfusion systems. Moreover, this new technology leads to efficient blood collection systems and expands the capability of autotransfusion systems in different surgeries.
Scope of the Autotransfusion Systems Market Report
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Autotransfusion Systems Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Product Type (Autotransfusion Systems and Consumables & Accessories), Application (Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological, Cardiovascular Surgeries, Organ & Tissue Transplantation, Trauma Procedures, and Others), and End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Applligent Technologies Pvt. Ltd.; B. Braun SE; BD; Braile Biomédica; Brightwake Ltd; Fresenius SE & Co. KGaA; Gen World Medical Device; Getinge; Haemonetics Corporation; LivaNova PLC; Medtronic; ProCell Surgical Inc.; Redax S.p.a.; SARSTEDT AG & Co. KG; Teleflex Incorporated; and Zimmer Biome |
Market Segment Insights
Product Type Analysis
Based on the product type, the autotransfusion systems market is divided into autotransfusion systems and consumables & accessories. The autotransfusion system segment is expected to hold a major market share during the forecast period, owing to its high adoption in critical surgeries, due to its efficient blood collection capabilities. Autotransfusions offer various advantages, such as reduced dependency on blood bank reserve, low morbidity rate, and less danger of isosensitization. Furthermore, this system is heavily been used for decades, owing to its safety and efficacy in managing blood loss, which further boosts the segment.
Application Analysis
On the basis of application, the market is classified as orthopedic surgeries, neurological surgeries, obstetrics & gynecological, cardiovascular surgeries, organ & tissue transplantation, trauma procedures, and others. The cardiovascular surgeries segment is anticipated to register a robust growth rate in the coming years, as the autotransfusion system is extremely utilized for maintaining a sterile field during cardiovascular surgeries. The system offers efficient management and recycling of the blood for patient safety. This device is majorly used to reduce the risk of blood contamination and significantly the requirement for donated blood. The growing prevalence of cardiovascular diseases across the globe is further likely to fuel the segment during the forecast period.
- According to the report published in 2020 by the National Library of Medicine, cardiovascular diseases including cerebrovascular and ischaemic heart diseases, such as stroke accounted for nearly 17.7 million deaths in India. Moreover, these heart diseases strike the population in India a decade earlier than the population in the West.
The orthopedic surgeries segment is expected to expand at a high CAGR during the forecast period, due to the rising number of orthopedic surgeries being performed among the geriatric population across the globe. Orthopedic surgeries involve the treatment of musculoskeletal conditions and injuries. The high occurrence of conditions, including joint replacements, fractures, and spine diseases has raised the need for orthopedic surgeries, which further boosts the demand for autotransfusion systems to avoid the risk of blood loss.
- According to a report published by the World Health Organization (WHO) on July 14, 2022, around 1.71 billion people live with musculoskeletal conditions globally.
End-user Analysis
In terms of end-user, the autotransfusion systems market is fragmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment is estimated to hold a key market share during the forecast period, owing to the growing number of surgeries performed in hospitals.
Hospitals provide the necessary equipment, including autotransfusion systems to operate a wide range of surgeries or medical processes. These surgeries often have a high risk of heavy blood loss during the procedures, which creates a high demand for blood management systems that fuels the autotransfusion market.
The specialty clinics segment is anticipated to expand at a significant pace, owing to the rising implementation of intraoperative and post-operative cell salvage in specialty clinics in developed regions. Specialty clinics are catering to specific medical specialties or procedures. These particularly focus on optimizing patient outcomes and improving blood management practices.
Intraoperative and post-operative cell salvage techniques involve collecting and reinfusing the patient blood. This aligns with the objective of blood conservation and reducing reliance on external blood sources. The emphasis on blood management in specialty clinics propels the adoption of autotransfusion systems globally.
Regional Outlook
On the basis of region, the global autotransfusion systems market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the global market during the forecast period, owing to the presence of advanced healthcare services and a high number of surgeries being performed in the region. The region is known for its well-established healthcare infrastructure, including well-equipped surgical facilities and a reliable network of healthcare providers, which increases the demand for autotransfusion devices in North America to ensure effective blood management during the medical procedure.
The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period, due to the increasing healthcare expenditures in the region. Countries such as China, India, and Japan are highly investing in the healthcare facilities and infrastructure. This further leads to the adoption of advanced medical technologies, including autotransfusion systems. Furthermore, this region is experiencing high prevalence of chronic diseases, such as cardiovascular diseases, cancer, and orthopedic conditions, which boosts the demand for surgical procedures and significantly autotransfusion systems to ensure the safe management of blood collection.
Segments
The global autotransfusion systems market has been segmented on the basis of
Product Type
- Autotransfusion System
- Consumables & Accessories
Application
- Orthopedic Surgeries
- Neurological Surgeries
- Obstetrics & Gynecological
- Cardiovascular Surgeries
- Organ & Tissue Transplantation
- Trauma Procedures
- Others
End-user
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinic
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Applligent Technologies Pvt. Ltd.
- B. Braun SE
- BD
- Braile Biomédica
- Brightwake Ltd
- Fresenius SE & Co. KGaA
- Gen World Medical Device
- Getinge
- Haemonetics Corporation
- LivaNova PLC
- Medtronic
- ProCell Surgical Inc.
- Redax S.p.a.
- SARSTEDT AG & Co. KG
- Teleflex Incorporated
- Zimmer Biome
Competitive Landscape
Key players competing in the global autotransfusion systems market are Applligent Technologies Pvt. Ltd.; B. Braun SE; BD; Braile Biomédica; Brightwake Ltd; Fresenius SE & Co. KGaA; Gen World Medical Device; Getinge; Haemonetics Corporation; LivaNova PLC; Medtronic; ProCell Surgical Inc.; Redax S.p.a.; SARSTEDT AG & Co. KG; Teleflex Incorporated; and Zimmer Biome.
Some of these companies adopt various strategies such as partnerships, mergers, launching new medical devices, and implementing advanced technologies in existing systems to cater to customers globally. For instance,
- On June 10, 2022, ProCell Surgical Inc., a patient blood management device provider, launched an autotransfusion medical device ProCell. This device offers an automated solution for the manual and outdated activity of surgical sponge-blood recovery. The ProCell is designed to enhance the surgical blood conservation efficiently of hospitals by using vacuum suction to extract blood from surgical sponges.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Autotransfusion Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Autotransfusion Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Autotransfusion Systems Market - Supply Chain
4.5. Global Autotransfusion Systems Market Forecast
4.5.1. Autotransfusion Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Autotransfusion Systems Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Autotransfusion Systems Market Absolute $ Opportunity
5. Global Autotransfusion Systems Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Autotransfusion Systems Market Size and Volume Forecast by Applications
5.3.1. Orthopedic Surgeries
5.3.2. Neurological Surgeries
5.3.3. Obstetrics & Gynecological
5.3.4. Cardiovascular Surgeries
5.3.5. Organ & Tissue Transplantation
5.3.6. Trauma Procedures
5.3.7. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Autotransfusion Systems Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Autotransfusion Systems Market Size and Volume Forecast by End Users
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Specialty Clinic
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Autotransfusion Systems Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Autotransfusion Systems Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Autotransfusion Systems Demand Share Forecast, 2019-2026
8. North America Autotransfusion Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Autotransfusion Systems Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Autotransfusion Systems Market Size and Volume Forecast by Applications
8.4.1. Orthopedic Surgeries
8.4.2. Neurological Surgeries
8.4.3. Obstetrics & Gynecological
8.4.4. Cardiovascular Surgeries
8.4.5. Organ & Tissue Transplantation
8.4.6. Trauma Procedures
8.4.7. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Autotransfusion Systems Market Size and Volume Forecast by End Users
8.7.1. Hospitals
8.7.2. Ambulatory Surgical Centers
8.7.3. Specialty Clinic
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Autotransfusion Systems Demand Share Forecast, 2019-2026
9. Latin America Autotransfusion Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Autotransfusion Systems Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Autotransfusion Systems Market Size and Volume Forecast by Applications
9.4.1. Orthopedic Surgeries
9.4.2. Neurological Surgeries
9.4.3. Obstetrics & Gynecological
9.4.4. Cardiovascular Surgeries
9.4.5. Organ & Tissue Transplantation
9.4.6. Trauma Procedures
9.4.7. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Autotransfusion Systems Market Size and Volume Forecast by End Users
9.7.1. Hospitals
9.7.2. Ambulatory Surgical Centers
9.7.3. Specialty Clinic
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Autotransfusion Systems Demand Share Forecast, 2019-2026
10. Europe Autotransfusion Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Autotransfusion Systems Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Autotransfusion Systems Market Size and Volume Forecast by Applications
10.4.1. Orthopedic Surgeries
10.4.2. Neurological Surgeries
10.4.3. Obstetrics & Gynecological
10.4.4. Cardiovascular Surgeries
10.4.5. Organ & Tissue Transplantation
10.4.6. Trauma Procedures
10.4.7. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Autotransfusion Systems Market Size and Volume Forecast by End Users
10.7.1. Hospitals
10.7.2. Ambulatory Surgical Centers
10.7.3. Specialty Clinic
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Autotransfusion Systems Demand Share Forecast, 2019-2026
11. Asia Pacific Autotransfusion Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Autotransfusion Systems Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Autotransfusion Systems Market Size and Volume Forecast by Applications
11.4.1. Orthopedic Surgeries
11.4.2. Neurological Surgeries
11.4.3. Obstetrics & Gynecological
11.4.4. Cardiovascular Surgeries
11.4.5. Organ & Tissue Transplantation
11.4.6. Trauma Procedures
11.4.7. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Autotransfusion Systems Market Size and Volume Forecast by End Users
11.7.1. Hospitals
11.7.2. Ambulatory Surgical Centers
11.7.3. Specialty Clinic
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Autotransfusion Systems Demand Share Forecast, 2019-2026
12. Middle East & Africa Autotransfusion Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Autotransfusion Systems Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Autotransfusion Systems Market Size and Volume Forecast by Applications
12.4.1. Orthopedic Surgeries
12.4.2. Neurological Surgeries
12.4.3. Obstetrics & Gynecological
12.4.4. Cardiovascular Surgeries
12.4.5. Organ & Tissue Transplantation
12.4.6. Trauma Procedures
12.4.7. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Autotransfusion Systems Market Size and Volume Forecast by End Users
12.7.1. Hospitals
12.7.2. Ambulatory Surgical Centers
12.7.3. Specialty Clinic
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Autotransfusion Systems Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Autotransfusion Systems Market: Market Share Analysis
13.2. Autotransfusion Systems Distributors and Customers
13.3. Autotransfusion Systems Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Applligent Technologies Pvt. Ltd.
13.4.2. B. Braun SE
13.4.3. BD
13.4.4. Braile Biomédica
13.4.5. Brightwake Ltd
13.4.6. Fresenius SE & Co. KGaA
13.4.7. Gen World Medical Device
13.4.8. Getinge
13.4.9. Haemonetics Corporation
13.4.10. LivaNova PLC
13.4.11. Medtronic
13.4.12. ProCell Surgical Inc.
13.4.13. Redax S.p.a.
13.4.14. SARSTEDT AG & Co. KG
13.4.15. Teleflex Incorporated
13.4.16. Zimmer Biome
Methodology
Related Reports
Some other reports from this category!
Our Clients
